Symbol="EXEL"
AssetType="Common Stock"
Name="Exelixis Inc"
Description="Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California."
CIK="939767"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="6463895000"
EBITDA="170311000"
PERatio="42.23"
PEGRatio="0.316"
BookValue="7.86"
DividendPerShare="0"
DividendYield="0"
EPS="0.47"
RevenuePerShareTTM="5.16"
ProfitMargin="0.0924"
OperatingMarginTTM="0.0884"
ReturnOnAssetsTTM="0.0317"
ReturnOnEquityTTM="0.0634"
RevenueTTM="1663870000"
GrossProfitTTM="1553153000"
DilutedEPSTTM="0.47"
QuarterlyEarningsGrowthYOY="-0.429"
QuarterlyRevenueGrowthYOY="0.148"
AnalystTargetPrice="24.93"
TrailingPE="42.23"
ForwardPE="10.58"
PriceToSalesRatioTTM="3.111"
PriceToBookRatio="2.042"
EVToRevenue="2.258"
EVToEBITDA="9.66"
Beta="0.67"
num_52WeekHigh="22.04"
num_52WeekLow="14.87"
num_50DayMovingAverage="19.35"
num_200DayMovingAverage="17.89"
SharesOutstanding="325637000"
DividendDate="None"
ExDividendDate="None"
symbol="EXEL"
open="19.66"
high="19.89"
low="19.64"
price="19.85"
volume="1780256.00"
latest_trading_day="2023-07-28"
previous_close="19.60"
change="0.25"
change_percent="1.2755%"
aroon_positive_momentum_days="88"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="2722847"
Change_recent_avg="0.03"
Delta_recent_avg="0.41"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0038.jpeg"
image_negative_thumbnail_id_2="1113"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0146.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="645"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_positive_thumbnail_id_2="957"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
